reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company's net income of $5,896,000 or $0.10 per diluted share compared to $3,686,000 or $0.07 per diluted share for the same period a year ago. Total net revenue was $82,393,000 compared with $75,972,000 for the same period a year ago. Operating income was $13,545,000 compared with $11,827,000 for the same period a year ago. Income before income taxes was $9,509,000 compared with $6,252,000 for the same period a year ago. Total non-GAAP Adjusted EBITDA $28,548,000 compared with $25,201,000 for the same period a year ago. Non-GAAP EBITDA was $24,708,000 compared with $22,151,000 for the same period a year ago. Non-GAAP cash diluted EPS was $0.22 compared with non-GAAP cash diluted EPS of $0.18 for the same period a year ago. For the nine months, the company's net income of $9,976,000 or $0.17 per diluted share compared to $4,809,000 or $0.09 per diluted share for the same period a year ago. Total net revenue was $245,586,000 compared with $195,965,000 for the same period a year ago. Operating income was $29,783,000 compared with $25,289,000 for the same period a year ago. Income before income taxes was $16,172,000 compared with $8,068,000 for the same period a year ago. Cash provided by operating activities was $39,951,000 compared with $31,105,000 for the same period a year ago. The company reported purchases of property, equipment, and software of $9,233,000 compared with $3,891,000 for the same period a year ago. Total non-GAAP Adjusted EBITDA was $75,391,000 compared with $60,267,000 for the same period a year ago. Non-GAAP EBITDA was $62,606,000 compared with $45,946,000 for the same period a year ago. Non-GAAP cash diluted EPS was $0.54 compared with non-GAAP cash diluted EPS of $0.44 for the same period a year ago. The company revised earnings guidance for the year ending December 31, 2009. For the year, the company expects total net revenue in the range of $341,000,000 to $345,000,000 compared to previous guidance of $346,000,000 to $354,000,000. The company expects diluted EPS in the range of $0.31 to $0.37 compared to previous guidance of $0.29 to $0.37. The company expects non-GAAP adjusted EBITDA in the range of $110,000,000 to $114,000,000. The company expects Non-GAAP cash diluted EPS in the range of $0.78 to $0.84 compared to previous guidance of $0.76 to $0.84. The company expects net income in the range of $18,100,000 to $21,200,000. The company expects non-GAAP EBITDA in the range of $92,400,000 to $96,800,000. The company expects non-GAAP adjusted EBITDA in the range of $110,000,000 to $114,000,000.

MedAssets Inc. has reached an agreement to become the primary group purchasing organization (GPO) and a technology provider for supply chain system optimization for Maury Regional Medical Center of Columbia, Tenn. MedAssets will help the integrated delivery network better serve its patients by achieving greater supply cost savings and efficiencies. Through this agreement, MedAssets will serve as the primary GPO to help the health system maximize its purchasing power. In addition to the GPO, MedAssets will also help Maury Regional to analyze and identify opportunities where the hospital can realize further savings on supplies and pharmaceuticals using MedAssets Strategic Information tools and advanced business intelligence technology. MedAssets will also provide a business analytical review that will help the health system to analyze its clinical costs and identify additional savings opportunities.

MedAssets Inc.'s Claims Auditor solution is now compatible with the American Hospital Association's (AHA) RACTrac, a Web-based survey that will collect data from hospitals to track and summarize the impact of RAC activity on individual hospitals nationwide. MedAssets Claims Auditor is a Web-based solution to help providers streamline and automate cumbersome RAC processes. MedAssets' Claims Auditor audits historical claims to assess risk and uses an interactive workflow and customized reporting to appeal RAC audit findings in a timely and efficient manner. The solution also links to MedAssets' market-leading coding and reference research tool and helps identify areas for improvement, such as compliance and reimbursement issues and/or omissions. AHA's RACTrac will collect data from general medical/surgical acute care hospitals, long-term acute care hospitals, inpatient rehabilitation hospitals and inpatient psychiatric hospitals. RACTrac's reports will be generated quarterly, and will help these hospitals understand the program's effect on them, as well as emerging trends, such as changes in the prevalent reasons for denials. MedAssets Claims Auditor helps providers cut through the complexities of Medicare claims and payments, replacing labor-intensive research and review with accurate, process improvement technology.